175 related articles for article (PubMed ID: 20846311)
1. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
Sellheyer K; Krahl D
Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
[TBL] [Abstract][Full Text] [Related]
2. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
Costache M; Bresch M; Böer A
Histopathology; 2008 Jun; 52(7):865-76. PubMed ID: 18462369
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
5. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
6. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
7. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
8. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
9. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
10. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma with matrical differentiation: expression of beta-catenin [corrected] and osteopontin.
Del Sordo R; Cavaliere A; Sidoni A
Am J Dermatopathol; 2007 Oct; 29(5):470-4. PubMed ID: 17890917
[TBL] [Abstract][Full Text] [Related]
12. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
Vidal VP; Ortonne N; Schedl A
J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
[TBL] [Abstract][Full Text] [Related]
13. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
14. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin.
Kanitakis J; Bourchany D; Faure M; Claudy A
Eur J Dermatol; 1999; 9(5):363-5. PubMed ID: 10417438
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
17. Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma.
Vollmer RT
J Cutan Pathol; 2009 Feb; 36(2):283; author reply 284. PubMed ID: 19208081
[No Abstract] [Full Text] [Related]
18. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
19. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
Kirchmann TT; Prieto VG; Smoller BR
Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
[TBL] [Abstract][Full Text] [Related]
20. Nestin expression in stromal cells of trichoblastoma and basal cell carcinoma.
Misago N; Mori T; Narisawa Y
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1354-8. PubMed ID: 20337823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]